Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Upstream names new CEO, CFO and COO

Plus: Acadia hires Elizabeth Thompson as head of R&D, and updates from Insitro, Fractyl, Adarx and more

April 4, 2024 12:15 AM UTC

Respiratory disease company Upstream Bio Inc. named Rand Sutherland CEO, Mike Gray CFO and COO, and Lisa Fiering as SVP of people and culture. Sutherland was CEO of Seeker Biologics, while Gray was CFO and COO at Carmot Therapeutics Inc., which was acquired by Roche (SIX:ROG; OTCQX:RHHBY). Fiering held several roles at Trillium Therapeutics Inc. and Rome Therapeutics Inc.

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) hired Elizabeth Thompson as EVP, head of R&D. Thompson was EVP, R&D (rare disease) at Amgen Inc. (NASDAQ:AMGN), following its acquistion of Horizon Therapeutics plc, where she led R&D...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article